Sign in

Trial result ·

18F-Fluorodeoxyglucose Positron Emission Tomography Imaging Assessment Within a Randomized Controlled Trial in Giant Cell Arteritis.

Written based on 1 research study on PubMed, searched on 15 Nov 2026.

What was studied

This study looked at people with giant cell arteritis, or GCA. Some had new disease, and some had disease that came back. They took part in a trial run in many centers and countries. By chance, each person got guselkumab or a dummy drug. Both groups also took steroid drugs, which were slowly cut down. Each person had a PET scan that shows activity in the arteries. Scans were done at the start, then at a flare or week 52. The team compared scans with symptoms, blood tests and steroid use.

What they found

At the start, scans showed active disease in 28 of 51 people. Scan activity at the start was not linked to symptoms or blood tests. It also did not show who would later flare. Younger people and women were more likely to have active scans. The ages were 70 versus 76 years. Earlier steroid dose and length did not differ between the groups. Scans were active in 17 of 21 people during a flare. At week 52, people were in remission and off steroids. Even so, scans were active in 14 of 20 of them. Some people had active scans at every visit, 21 in all. And 9 people had inactive scans at every visit. This held true whatever the doctors' own checks showed.

What it means for patients

PET scan activity may not agree with how doctors judge the disease. This may be more so in some groups of people with GCA. The authors say scan-based results should stay exploratory in future drug trials.

Why it is not certain yet

The study had 51 people with a scan at the start. Fewer had repeat scans: 21 at a flare and 20 at week 52. The abstract does not explain why scans and symptoms did not agree. It also does not say if guselkumab changed the scan results.

Source

18F-Fluorodeoxyglucose Positron Emission Tomography Imaging Assessment Within a Randomized Controlled Trial in Giant Cell Arteritis.

PubMed · PMID 41940456

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Giant cell arteritis publications